Task Performance and AnalysisNCT02778373
Comparative Effects of Post-exercise Ingestion of a High or Low Molecular Weight Solution on Resistance Exercise Performance
A study testing Vitargo ®, Swecarb AB, Karlskrona, Sweden and DE15 maltodextrin, Matrin® M160, Grain Processing Corporation, Muscatine, IA in people with Task Performance and Analysis, run by Texas Christian University.
Trial summary
This study sought to examine differences in resistance exercise performance, as measured by the kinetic and kinematic profile during multiple sets of the back squat exercise, following ingestion of high or low molecular weight carbohydrate beverages. Read more about this study
- Who is it for?
- Ages 20 to 35 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Task Performance and Analysis
- What is being tested?
- Vitargo ®, Swecarb AB, Karlskrona, Sweden and DE15 maltodextrin, Matrin® M160, Grain Processing Corporation, Muscatine, IA
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- Sep 2014to Jun 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 35 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- having at least 2 years resistance training experience to include the parallel back squat exercise at least once a week
- no musculoskeletal injury within previous 1 year
- not having consumed any nutritional or ergogenic supplement excluding protein and/or a daily vitamin for the previous 6-week period
Who cannot join
- no previous resistance training experience
- musculoskeletal injury within the previous 1 year
- having consumed or presenting consuming a nutritional or ergogenic supplement
About this study
This study sought to examine differences in resistance exercise performance, as measured by the kinetic and kinematic profile during multiple sets of the back squat exercise, following ingestion of high or low molecular weight carbohydrate beverages.
- Conditions
- Task Performance and Analysis
- Being tested
- Vitargo ®, Swecarb AB, Karlskrona, Sweden, DE15 maltodextrin, Matrin® M160, Grain Processing Corporation, Muscatine, IA, Placebo: Water
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Vitargo ®, Swecarb AB, Karlskrona, SwedenDietary supplement
DE15 maltodextrin, Matrin® M160, Grain Processing Corporation, Muscatine, IADietary supplement
Placebo: WaterOther
| Study group | Role | What they receive |
|---|---|---|
| Placebo | Placebo comparator | Flavored Water Receives: Other: Placebo: Water |
| Low Molecular Weight Carbohydrate | Active comparator | low molecular weight carbohydrate delivered post-endurance exercise in a 10% solution providing 1.2 grams/kg body weight carbohydrate Receives: Dietary Supplement: DE15 maltodextrin, Matrin® M160, Grain Processing Corporation, Muscatine, IA |
| High molecular weight carbohydrate | Experimental | high molecular weight carbohydrate delivered post-endurance exercise in a 10% solution providing 1.2 grams/kg body weight carbohydrate Receives: Dietary Supplement: Vitargo ®, Swecarb AB, Karlskrona, Sweden |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Power Output
Change in power output, measured in watts, will be examined over the course of the performance of 5 sets of 10 repetitions of the back squat exercise with a weight corresponding to 75% one-repetition maximum.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2016 (estimated)
- Study startSep 2014
- Primary completionJun 2015
- Study completionJun 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Task Performance and AnalysisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Texas Christian University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02778373
- Sponsor's protocol ID
- 1401-45-1401
- Status last verified
- May 2016
- First submitted
- 12 May 2016
- Last updated
- 19 May 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- Yes
Publications
Piehl Aulin K, Soderlund K, Hultman E. Muscle glycogen resynthesis rate in humans after supplementation of drinks containing carbohydrates with low and high molecular masses. Eur J Appl Physiol. 2000 Mar;81(4):346-51. doi: 10.1007/s004210050053.
PubMed 10664095Leiper JB, Aulin KP, Soderlund K. Improved gastric emptying rate in humans of a unique glucose polymer with gel-forming properties. Scand J Gastroenterol. 2000 Nov;35(11):1143-9. doi: 10.1080/003655200750056600.
PubMed 11145284Stephens FB, Roig M, Armstrong G, Greenhaff PL. Post-exercise ingestion of a unique, high molecular weight glucose polymer solution improves performance during a subsequent bout of cycling exercise. J Sports Sci. 2008 Jan 15;26(2):149-54. doi: 10.1080/02640410701361548.
PubMed 17852670Oliver JM, Almada AL, Van Eck LE, Shah M, Mitchell JB, Jones MT, Jagim AR, Rowlands DS. Ingestion of High Molecular Weight Carbohydrate Enhances Subsequent Repeated Maximal Power: A Randomized Controlled Trial. PLoS One. 2016 Sep 16;11(9):e0163009. doi: 10.1371/journal.pone.0163009. eCollection 2016.
PubMed 27636206
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Effects of Post-exercise Ingestion of a High or Low Molecular Weight Solution on Resistance Exercise Performance
- ClinicalTrials.gov ID
- NCT02778373
- Acronym / sponsor ID
- 1401-45-1401
- Conditions
- Task Performance and Analysis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Texas Christian UniversityUniversity, hospital or other
- Study start
- Sep 2014
- Primary completion
- Jun 2015 (actual)
- Study completion
- Jun 2015 (actual)
- First posted
- 19 May 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study sought to examine differences in resistance exercise performance, as measured by the kinetic and kinematic profile during multiple sets of the back squat exercise, following ingestion of high or low molecular weight carbohydrate beverages.
Study design
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Placebo | Placebo comparator | Other: Placebo: WaterFlavored Water |
| Low Molecular Weight Carbohydrate | Active comparator | Dietary Supplement: DE15 maltodextrin, Matrin® M160, Grain Processing Corporation, Muscatine, IAlow molecular weight carbohydrate delivered post-endurance exercise in a 10% solution providing 1.2 grams/kg body weight carbohydrate |
| High molecular weight carbohydrate | Experimental | Dietary Supplement: Vitargo ®, Swecarb AB, Karlskrona, Swedenhigh molecular weight carbohydrate delivered post-endurance exercise in a 10% solution providing 1.2 grams/kg body weight carbohydrate |
Who may qualify
- Ages
- 20 to 35 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- having at least 2 years resistance training experience to include the parallel back squat exercise at least once a week
- no musculoskeletal injury within previous 1 year
- not having consumed any nutritional or ergogenic supplement excluding protein and/or a daily vitamin for the previous 6-week period
Key exclusion criteria (3 listed)
- no previous resistance training experience
- musculoskeletal injury within the previous 1 year
- having consumed or presenting consuming a nutritional or ergogenic supplement
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Vitargo ®, Swecarb AB, Karlskrona, Sweden | Dietary supplement | High molecular weight carbohydrate |
| DE15 maltodextrin, Matrin® M160, Grain Processing Corporation, Muscatine, IA | Dietary supplement | Low Molecular Weight Carbohydrate |
| Placebo: Water | Other | Placebo |
Primary outcome
Change in Power Output
Time frame: 1 year
Change in power output, measured in watts, will be examined over the course of the performance of 5 sets of 10 repetitions of the back squat exercise with a weight corresponding to 75% one-repetition maximum.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2016.
- Background: PubMed 10664095Piehl Aulin K, Soderlund K, Hultman E. Muscle glycogen resynthesis rate in humans after supplementation of drinks containing carbohydrates with low and high molecular masses. Eur J Appl Physiol. 2000 Mar;81(4):346-51. doi: 10.1007/s004210050053.
- Background: PubMed 11145284Leiper JB, Aulin KP, Soderlund K. Improved gastric emptying rate in humans of a unique glucose polymer with gel-forming properties. Scand J Gastroenterol. 2000 Nov;35(11):1143-9. doi: 10.1080/003655200750056600.
- Background: PubMed 17852670Stephens FB, Roig M, Armstrong G, Greenhaff PL. Post-exercise ingestion of a unique, high molecular weight glucose polymer solution improves performance during a subsequent bout of cycling exercise. J Sports Sci. 2008 Jan 15;26(2):149-54. doi: 10.1080/02640410701361548.
- Derived from this study: PubMed 27636206Oliver JM, Almada AL, Van Eck LE, Shah M, Mitchell JB, Jones MT, Jagim AR, Rowlands DS. Ingestion of High Molecular Weight Carbohydrate Enhances Subsequent Repeated Maximal Power: A Randomized Controlled Trial. PLoS One. 2016 Sep 16;11(9):e0163009. doi: 10.1371/journal.pone.0163009. eCollection 2016.
- Individual participant dataSharing planned: Yes
Related trials for Task Performance and Analysis
Active, not recruiting
Impact of Force Feedback in VR Training on EEG Biomarkers and Real-World Motor Performance
Motor Skills, Healthy Volunteer
RecruitingObservational study
Dual-Task Effects on Gait and Balance in MCRS
Motoric Cognitive Risk Syndrome, Dual-Task Performance
Not yet recruiting
Knee Osteoarthritis, Motor Control, Risk of Falls and Virtual Reality
Knee Osteoarthritis, Task Performance and Analysis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Vitargo ®, Swecarb AB, Karlskrona, Sweden and DE15 maltodextrin, Matrin® M160, Grain Processing Corporation, Muscatine, IA in people with Task Performance and Analysis, run by Texas Christian University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 May 2016. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Power Output (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02778373, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2016.